- Home
- VCYT vs ADX Comparison
VCYT vs ADX Comparison
Compare VCYT & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCYT | ADX |
|---|---|---|
| Founded | 2006 | 1840 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCYT | ADX |
|---|---|---|
| Price | $42.32 | $23.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $45.38 | N/A |
| AVG Volume (30 Days) | ★ 769.3K | 182.4K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $495,141,000.00 | N/A |
| Revenue This Year | $16.16 | N/A |
| Revenue Next Year | $10.92 | N/A |
| P/E Ratio | $111.69 | ★ N/A |
| Revenue Growth | ★ 16.41 | N/A |
| 52 Week Low | $22.61 | $14.94 |
| 52 Week High | $50.71 | $19.57 |
Technical Indicators
Market Signals| Indicator | VCYT | ADX |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 59.81 |
| Support Level | $41.90 | $22.30 |
| Resistance Level | $43.86 | $23.45 |
| Average True Range (ATR) | 1.35 | 0.26 |
| MACD | -0.37 | 0.08 |
| Stochastic Oscillator | 24.45 | 91.18 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.